Literature DB >> 15023580

Prepulse facilitation and prepulse inhibition in schizophrenia patients and their unaffected siblings.

Jonathan K Wynn1, Michael E Dawson, Anne M Schell, Mark McGee, Dustin Salveson, Michael F Green.   

Abstract

BACKGROUND: Deficits in schizophrenia patients and their first-degree relatives have been reported in prepulse inhibition (PPI), a phenomenon that measures an early stage of information processing (sensorimotor gating). It is less clear whether these information processing deficits extend to prepulse facilitation (PPF), which measures a later stage of generalized alerting or orienting.
METHODS: This study examined three separate issues: first, whether schizophrenia patients have deficits in PPI and PPF; second, whether the siblings of patients show deficits in these processes; and third, whether prepulse duration influences the degree of the deficits. These issues were examined in 76 schizophrenia patients, 36 of their siblings, and 41 normal control subjects.
RESULTS: Patients and siblings did not differ from control subjects in PPI, perhaps due to the use of different procedural parameters compared with other laboratories that have consistently found PPI deficits in schizophrenia patients. Patients and their siblings produced significantly less PPF than control subjects. For both PPI and PPF, prepulse duration was not a significant factor.
CONCLUSIONS: These results imply that PPF deficits reveal a generalized alerting or orienting deficit that is present in both schizophrenia patients and their siblings, suggesting that this deficit may be tapping an endophenotypic vulnerability factor.

Entities:  

Mesh:

Year:  2004        PMID: 15023580     DOI: 10.1016/j.biopsych.2003.10.018

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  28 in total

1.  Parental history of type 2 diabetes in patients with nonaffective psychosis.

Authors:  Emilio Fernandez-Egea; Brian Miller; Miguel Bernardo; Thomas Donner; Brian Kirkpatrick
Journal:  Schizophr Res       Date:  2007-11-26       Impact factor: 4.939

2.  Interaction between the effects of corticotropin-releasing factor and prepulse parameters on prepulse inhibition in two inbred rat strains and the F1 generation of a cross between them.

Authors:  Lisa H Conti; Jane E Sutherland; Carey M Muhlhauser
Journal:  Behav Brain Res       Date:  2009-06-08       Impact factor: 3.332

Review 3.  Neuromodulation by the immune system: a focus on cytokines.

Authors:  Andrea Francesca Salvador; Kalil Alves de Lima; Jonathan Kipnis
Journal:  Nat Rev Immunol       Date:  2021-03-01       Impact factor: 53.106

4.  Heritability of acoustic startle magnitude, prepulse inhibition, and startle latency in schizophrenia and control families.

Authors:  Wendy Hasenkamp; Michael P Epstein; Amanda Green; Lisette Wilcox; William Boshoven; Barbara Lewison; Erica Duncan
Journal:  Psychiatry Res       Date:  2010-05-16       Impact factor: 3.222

5.  The glutamatergic compounds sarcosine and N-acetylcysteine ameliorate prepulse inhibition deficits in metabotropic glutamate 5 receptor knockout mice.

Authors:  Hwei-Hsien Chen; Astrid Stoker; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2010-03-10       Impact factor: 4.530

6.  Meta-Analysis of Sensorimotor Gating Deficits in Patients With Schizophrenia Evaluated by Prepulse Inhibition Test.

Authors:  Rodrigo San-Martin; Leonardo Andrade Castro; Paulo Rossi Menezes; Francisco José Fraga; Priscyla Waleska Simões; Cristiane Salum
Journal:  Schizophr Bull       Date:  2020-12-01       Impact factor: 9.306

7.  Altered object-in-place recognition memory, prepulse inhibition, and locomotor activity in the offspring of rats exposed to a viral mimetic during pregnancy.

Authors:  J G Howland; B N Cazakoff; Y Zhang
Journal:  Neuroscience       Date:  2011-11-11       Impact factor: 3.590

Review 8.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

9.  Nicotine effect on prepulse inhibition and prepulse facilitation in schizophrenia patients.

Authors:  L Elliot Hong; Ikwunga Wonodi; Jada Lewis; Gunvant K Thaker
Journal:  Neuropsychopharmacology       Date:  2007-10-24       Impact factor: 7.853

10.  Smooth pursuit eye movement, prepulse inhibition, and auditory paired stimuli processing endophenotypes across the schizophrenia-bipolar disorder psychosis dimension.

Authors:  Elena I Ivleva; Amanda F Moates; Jordan P Hamm; Ira H Bernstein; Hugh B O'Neill; Darwynn Cole; Brett A Clementz; Gunvant K Thaker; Carol A Tamminga
Journal:  Schizophr Bull       Date:  2013-04-18       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.